ENHYPEN's schedule for their ongoing world tour "FATE PLUS" has led a myriad of fans to call out BELIFT LAB online.
Here's what happened.
ENHYPEN's 'Hectic' World Tour Schedule for 'FATE PLUS' Receives Backlash, BELIFT LAB Criticized by ENGENEs
On February 7, BELIFT LAB officially announced the tour schedule for ENHYPEN's encore tour in the United States, "FATE PLUS."
According to their announcement, the tour will take place in five cities in the U.S. and will kickstart on April 24 in Anaheim. Following this, ENHYPEN will then head on to Oakland on April 26, trailed by Tacoma (April 28), Rosemont (May 1), and Belmont Park (May 3).
On Weverse, BELIFT LAB also released an official notice regarding ticket information and expressed enthusiasm over ENHYPEN's upcoming encore tour.
"Hello. This is BELIFT LAB.
ENYEN WORLD TOUR 'FATE PLUS' IN U.S. will be held soon! We look forward to your interest and support in ENHYPEN WORLD TOUR 'FATE PLUS' IN U.S.
We would like to share some information on the ticket reservations for the ENHYPEN WORLD TOUR 'FATE PLUS'IN U.S. tour."
While the announcement was supposed to make the fandom excited since ENHYPEN was about to do more shows, many were worried for the boys' well-being due to the onslaught of schedules.
ENGENEs voiced out that BELIFT LAB and HYBE didn't need to delegate another set of itineraries for ENHYPEN, since the group had just finished their "FATE" world tour across Asia. Fans also demanded the agency to let ENHYPEN rest for the meantime.
Read also: ENHYPEN Unveils 'DIMENSION: DILEMMA' Promotion Schedule + Celebrates 1st Debut Anniversary
Read their reactions below:
In other news, BELIFT LAB received the brunt of ENGENEs after many had claimed that one of ENHYPEN's vlogs was "wrongfully" edited. The incident caused the hashtag of "BELIFT_APOLOGIZE" to spike across social media.
Read also: here
What are your thoughts on ENHYPEN taking another tour? Are you looking forward to their shows? Let us know in the comments below!
Read KpopStarz for more K-pop news.
Read also: ENHYPEN's 'DARK BLOOD' Achieves 7-Week Streak on Billboard 200 + Becomes Group's 1st Album to Do So